NEA Management Company, LLC
26 holdingsFiling period: 2026-06-30Current AUM: $1.37Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | TRVI | Trevi Therapeutics, Inc. | 13.22M | $246.6M | $178.8M | 13.05% | -- | 2026-06-30 |
| 2 | MBX | MBX Biosciences, Inc. | 3.61M | $199.5M | $195.8M | 14.29% | -- | 2026-06-30 |
| 3 | GLUE | Monte Rosa Therapeutics, Inc. | 7.69M | $186.2M | $83.5M | 6.09% | -- | 2026-06-30 |
| 4 | CELC | Celcuity Inc. | 1.71M | $179.0M | $118.8M | 8.67% | -575,000 | 2026-06-30 |
| 5 | SGP | Spyglass Pharma, Inc. | 7.39M | $164.6M | $242.9M | 17.73% | -- | 2026-06-30 |
| 6 | SVRA | Savara, Inc. | 24.47M | $150.7M | $122.8M | 8.97% | -- | 2026-06-30 |
| 7 | ZBIO | Zenas BioPharma, Inc. | 4.02M | $102.1M | $115.7M | 8.45% | -- | 2026-06-30 |
| 8 | COUR | Coursera, Inc. | 12.87M | $72.6M | $60.5M | 4.41% | -- | 2026-06-30 |
| 9 | AUPH | Aurinia Pharmaceuticals, Inc. | 3.97M | $67.4M | $68.9M | 5.03% | -- | 2026-06-30 |
| 10 | — | CRISPR Therapeutics AG | 1.06M | $57.7M | $57.7M | 4.21% | -- | 2026-06-30 |
| 11 | ORIC | ORIC Pharmaceuticals, Inc. | 4.12M | $44.6M | $38.3M | 2.80% | -- | 2026-06-30 |
| 12 | PHAT | Phathom Pharmaceuticals, Inc. | 1.96M | $21.3M | $12.3M | 0.90% | -- | 2026-06-30 |
| 13 | KRRO | Korro Bio, Inc. | 1.30M | $17.1M | $18.0M | 1.31% | -- | 2026-06-30 |
| 14 | ASNS | X4 Pharmaceuticals, Inc. | 3.23M | $15.1M | $15.1M | 1.10% | -- | 2026-06-30 |
| 15 | CSBR | Champions Oncology, Inc. | 1.71M | $10.6M | $8.4M | 0.62% | -- | 2026-06-30 |
| 16 | NKTX | Nkarta, Inc. | 3.57M | $10.1M | $6.1M | 0.45% | -- | 2026-06-30 |
| 17 | CVRX | CVRx, Inc. | 1.95M | $10.0M | $2.7M | 0.20% | -71,643 | 2026-06-30 |
| 18 | BDTX | Black Diamond Therapeutics, Inc. | 4.45M | $8.2M | $8.1M | 0.59% | -- | 2026-06-30 |
| 19 | KPTI | Karyopharm Therapeutics Inc. | 576.8K | $5.6M | $480K | 0.04% | -- | 2026-06-30 |
| 20 | IVA | Inventiva SA | 1.46M | $5.5M | $5.4M | 0.40% | -- | 2026-06-30 |
| 21 | LONA | LeonaBio, Inc. | 464.4K | $4.3M | $2.3M | 0.17% | -- | 2026-06-30 |
| 22 | — | Senti Biosciences, Inc. | 3.78M | $4.2M | $4.2M | 0.30% | -- | 2026-06-30 |
| 23 | MRKR | Marker Therapeutics, Inc. | 1.63M | $2.4M | $1.6M | 0.12% | -- | 2026-06-30 |
| 24 | OKUR | OnKure Therapeutics, Inc. | 478.5K | $2.2M | $1.3M | 0.09% | -- | 2026-06-30 |
| 25 | IMA | ImageneBio, Inc. | 50.0K | $295K | $210K | 0.02% | -- | 2026-06-30 |
← Scroll →
Page 1 of 2